Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a combination therapy consisting of ...

Newsweek spoke with three doctors about the rising rates of colorectal cancer in young people and the lifestyle changes that ...

Colorectal cancer is now the leading killer for those under 50. Two individuals have shared their experiences with Newsweek.

Let’s start with the cheapest, the yearly FIT, or fecal immunochemical test, which looks for fecal blood that might be caused ...

James Van Der Beek is attempting to remain in good spirits as he battles stage 3 colorectal cancer. The "Dawson’s Creek" star opened up about the challenges he has faced during his cancer journey. Van ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

James Van Der Beek was sure that he was on top of his health — but then he was diagnosed with Stage 3 colon cancer. After ...

Mike Lowe, a WGN anchor, was diagnosed with Stage 3 colon cancer at the age of 40, and is now undergoing chemotherapy and radiation to fight the disease, while his best friend Peter Lee provides ...

James Van Der Beek is focused on his recovery after being diagnosed with stage 3 colorectal cancer ... earlier this month ...

A new study from the USC Norris Comprehensive Cancer Center has found evidence that targeting CD47, a protein that is part of the innate immune system, could be a key step in fighting colorectal ...

Some bacteria can cause mutations associated with colon cancer. Insights about the surface adhesion proteins that enable ...

Chemotherapy for three months demonstrates lower side effects, suggesting its use as standard care compared with six months.